Semaglutide induces weight loss for nonresponders to bariatric surgery

Adults who initiated once-weekly semaglutide after not responding to bariatric surgery lost a similar amount of weight as those without a history of bariatric surgery, according to study findings published in Obesity.
In a retrospective analysis of adults with a BMI of 40 kg/m2 or higher who were prescribed once-weekly semaglutide 2.4 mg (Wegovy, Novo Nordisk), those who previously underwent bariatric surgery and did not lose a sufficient amount of weight or regained weight after the procedure lost 9.8% of their body weight at 24 weeks and achieved an excess weight loss of 23.2%.

Leave a Comment

Your email address will not be published. Required fields are marked *

Shopping Cart